Literature DB >> 8461162

[Neurological complications of varicella-zoster virus (VZV) infection].

H Shiihara1.   

Abstract

Sixty cases with varicella-associated neurological disorders from Japanese literature during recent 11 years were analyzed and compared with previous reports. Chief diseases were encephalitis (encephalopathy) (23.3%), cerebellar ataxia (21.7%), meningitis (18.3%), cerebral infarction (13.3%) and facial palsy (8.3%). Cerebellar ataxia, meningitis and cerebral infarction were found in young children under 9 years, and other disorders were seen also in older children and adults. Some cases had neurological symptoms before the appearance of skin rash. The number of cells in cerebrospinal fluid was increased in meningitis, encephalitis and myelitis. Though neurological complications due to varicella were rare, prognosis was not necessarily good, including several cases with death or severe sequelae. In our 4 cases of herpes zoster meningitis, marked intrathecal VZV-specific antibody production was found and they showed high antibody index. Oligoclonal band was found in one case. The pathogenesis of neurological complications of VZV infection was considered to be caused by direct viral invasion in herpes zoster and at least in some cases of varicella. Therapy with antiviral agents is necessary and vaccination is recommended for prevention.

Entities:  

Mesh:

Year:  1993        PMID: 8461162

Source DB:  PubMed          Journal:  No To Hattatsu        ISSN: 0029-0831


  3 in total

1.  Post chicken pox neurological sequelae: Three distinct presentations.

Authors:  Rudrajit Paul; Pankaj Singhania; Ma Hashmi; Ramtanu Bandyopadhyay; Amit Kumar Banerjee
Journal:  J Neurosci Rural Pract       Date:  2010-07

2.  Acute peripheral facial palsy after chickenpox: a rare association.

Authors:  Helena Ferreira; Angela Dias; Andreia Lopes
Journal:  Case Rep Pediatr       Date:  2014-06-25

3.  Isolated Lower Motor Neuron Facial Nerve Palsy in a Patient of Varicella: A Case Report.

Authors:  Sanjiv Choudhary; Ankita Srivastava; Soumya Narula
Journal:  JNMA J Nepal Med Assoc       Date:  2020-04-30       Impact factor: 0.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.